Terms: = Bone cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Treatment
1651 results:
1. Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas.
Puccio J; Huang Y; Viveiros MD; Reneau JC; Chung C; Spaccarelli N; Dulmage B
Arch Dermatol Res; 2024 May; 316(5):199. PubMed ID: 38775835
[TBL] [Abstract] [Full Text] [Related]
2. Three-dimensional printed custom-made modular talus prosthesis in patients with talus malignant tumor resection.
He X; Lu M; Zou C; Li Z; Gong T; Kenmegne GR; Wang Y; Luo Y; Zhou Y; Min L; Tu C
J Orthop Surg Res; 2024 May; 19(1):273. PubMed ID: 38698477
[TBL] [Abstract] [Full Text] [Related]
3. Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome.
Consiglieri G; Tucci F; De Pellegrin M; Guerrini B; Cattoni A; Risca G; Scarparo S; Sarzana M; Pontesilli S; Mellone R; Gasperini S; Galimberti S; Silvani P; Filisetti C; Darin S; Forni G; Miglietta S; Santi L; Facchini M; Corti A; Fumagalli F; Cicalese MP; Calbi V; Migliavacca M; Barzaghi F; Ferrua F; Gallo V; Recupero S; Canarutto D; Doglio M; Tedesco L; Volpi N; Rovelli A; la Marca G; Valsecchi MG; Zancan S; Ciceri F; Naldini L; Baldoli C; Parini R; Gentner B; Aiuti A; Bernardo ME
Sci Transl Med; 2024 May; 16(745):eadi8214. PubMed ID: 38691622
[TBL] [Abstract] [Full Text] [Related]
4. Plant-Based Diets and Disease Progression in Men With Prostate cancer.
Liu VN; Van Blarigan EL; Zhang L; Graff RE; Loeb S; Langlais CS; Cowan JE; Carroll PR; Chan JM; Kenfield SA
JAMA Netw Open; 2024 May; 7(5):e249053. PubMed ID: 38691361
[TBL] [Abstract] [Full Text] [Related]
5. Microwave ablation combined with percutaneous vertebroplasty for treating painful non-small cell lung cancer with spinal metastases under real-time temperature monitoring.
Wu L; Hu M; Li P; Man Q; Yuan Q; Zhang X; Qiu Y; Chen L; Fan J; Zhang K
J Cancer Res Ther; 2024 Apr; 20(2):540-546. PubMed ID: 38687923
[TBL] [Abstract] [Full Text] [Related]
6. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diseases and Injuries Collaborators
Lancet; 2024 May; 403(10440):2133-2161. PubMed ID: 38642570
[TBL] [Abstract] [Full Text] [Related]
7. Travel burdens to access care among children with cancer between 2016 and 2019: Analysis of a national population-based cancer registry in Japan.
Tsutsui A; Murakami Y; Okamura S; Fujimaki T; Endo M; Ohno Y
PLoS One; 2024; 19(4):e0300840. PubMed ID: 38625911
[TBL] [Abstract] [Full Text] [Related]
8. ISIT-QA: In Silico Imaging Trial to Evaluate a Low-Count Quantitative SPECT Method Across Multiple Scanner-Collimator Configurations for
Li Z; Benabdallah N; Luo J; Wahl RL; Thorek DLJ; Jha AK
J Nucl Med; 2024 May; 65(5):810-817. PubMed ID: 38575187
[TBL] [Abstract] [Full Text] [Related]
9. Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research.
Newman H; Li Y; Huang YV; Elgarten CW; Myers RM; Ruiz J; Zheng DJ; Leahy AB; Aftandilian C; Arnold SD; Bona K; Gramatges MM; Heneghan MB; Maloney KW; Modi AJ; Mody RJ; Morgan E; Rubnitz J; Winick N; Wilkes JJ; Seif AE; Fisher BT; Aplenc R; Getz KD
Cancer Med; 2024 Apr; 13(7):e6966. PubMed ID: 38572962
[TBL] [Abstract] [Full Text] [Related]
10. Tumor treating fields suppress tumor cell growth and neurologic decline in models of spinal metastases.
Ledbetter D; de Almeida RAA; Wu X; Naveh A; Patel CB; Gonzalez Q; Beckham TH; North R; Rhines L; Li J; Ghia A; Aten D; Tatsui C; Alvarez-Breckenridge C
JCI Insight; 2024 Mar; 9(9):. PubMed ID: 38512420
[TBL] [Abstract] [Full Text] [Related]
11. Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis.
Chavez JC; Grajales A; Sandoval-Sus J; Turba E; Nodzon L; Uriepero-Palma A; Ammad-Ud-Din M; Sahakian E; Komrokji R; Sokol L; Locke FL; Shah B; Lancet J; Sotomayor EM; Kharfan-Dabaja MA; Bello C; Pinilla-Ibarz J
Clin Lymphoma Myeloma Leuk; 2024 Jun; 24(6):382-391.e2. PubMed ID: 38508880
[TBL] [Abstract] [Full Text] [Related]
12. [Analysis of the outcome of 12 cases of facial nerve tumors].
Shao Z; Zhou M; Yang J; Wang K
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Mar; 38(3):225-229. PubMed ID: 38433692
[No Abstract] [Full Text] [Related]
13. Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab.
Chandrakasan S; Jordan MB; Baker A; Behrens EM; Bhatla D; Chien M; Eckstein OS; Henry MM; Hermiston ML; Hinson AP; Leiding JW; Oladapo A; Patel SA; Pednekar P; Ray AK; Dávila Saldaña B; Sarangi SN; Walkovich KJ; Yee JD; Zoref-Lorenz A; Allen CE
Blood Adv; 2024 May; 8(9):2248-2258. PubMed ID: 38429096
[TBL] [Abstract] [Full Text] [Related]
14. Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study.
Eigler C; McDougall L; Bauman A; Bernhardt P; Hentschel M; Blackham KA; Nicolas G; Fani M; Wild D; Cordier D
J Nucl Med; 2024 Apr; 65(4):573-579. PubMed ID: 38423782
[TBL] [Abstract] [Full Text] [Related]
15. Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.
Baumrin E; Shin DB; Mitra N; Pidala J; El Jurdi N; Lee SJ; Loren AW; Gelfand JM
JAMA Dermatol; 2024 Apr; 160(4):393-401. PubMed ID: 38416506
[TBL] [Abstract] [Full Text] [Related]
16. treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms.
Streuer A; Jann JC; Boch T; Mossner M; Riabov V; Schmitt N; Altrock E; Xu Q; Demmerle M; Nowak V; Oblaender J; Palme I; Weimer N; Rapp F; Metzgeroth G; Hecht A; Höger T; Merz C; Hofmann WK; Nolte F; Nowak D
Ann Hematol; 2024 Apr; 103(4):1221-1233. PubMed ID: 38413410
[TBL] [Abstract] [Full Text] [Related]
17. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
18. Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency treatment Consortium study.
Grunebaum E; Arnold DE; Logan B; Parikh S; Marsh RA; Griffith LM; Mallhi K; Chellapandian D; Lim SS; Deal CL; Kapoor N; Murguía-Favela L; Falcone EL; Prasad VK; Touzot F; Bleesing JJ; Chandrakasan S; Heimall JR; Bednarski JJ; Broglie LA; Chong HJ; Kapadia M; Prockop S; Dávila Saldaña BJ; Schaefer E; Bauchat AL; Teira P; Chandra S; Parta M; Cowan MJ; Dvorak CC; Haddad E; Kohn DB; Notarangelo LD; Pai SY; Puck JM; Pulsipher MA; Torgerson TR; Malech HL; Kang EM; Leiding JW
J Allergy Clin Immunol; 2024 May; 153(5):1423-1431.e2. PubMed ID: 38290608
[TBL] [Abstract] [Full Text] [Related]
19. Erythroid variant evolving from chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitors: a rare case report.
Lee MH; Song A; Li JY
Diagn Pathol; 2024 Jan; 19(1):21. PubMed ID: 38268039
[TBL] [Abstract] [Full Text] [Related]
20. Long-term outcomes with HLX01 (HanliKang
Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
[TBL] [Abstract] [Full Text] [Related]
[Next]
